Exenatide improves postprandial hyperglycemia and dyslipidemia in metformin treated patients with type 2 diabetes

被引：0
|
作者：
Bunck, Mathijs C.
Corner, Anja
Diamant, Michaela
Eliasson, Bjorn
Malloy, Jaret L.
Shaginian, Rimma M.
Ding, Wei
Kendall, David M.
Smith, Ulf
Yki-Jarvinen, Hannele
Heine, Robert J.
Taskinen, Marja-Ritta
机构：
来源：
DIABETES | 2008年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A33 / A33
页数：1
相关论文
共 50 条
  • [41] Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?
    Dziegielewska-Gesiak, Sylwia
    Fatyga, Edyta
    Pilot, Magdalena
    Wierzgon, Aleksander
    Muc-Wierzgon, Malgorzata
    DIABETES METABOLIC SYNDROME AND OBESITY, 2022, 15 : 3589 - 3599
  • [42] Exenatide improves acute phase insulin response to a meal in patients with type 2 diabetes
    Han, J.
    Dong, H.
    Nielsen, L.
    Qu, Y.
    Glass, L.
    Bhole, D.
    Maggs, D.
    DIABETOLOGIA, 2008, 51 : S345 - S345
  • [43] One-year exenatide treatment improves beta cell response in metformin treated patients with type 2 diabetes which is sustained after 5 weeks discontinuation of treatment
    Bunck, M. C.
    Mari, A.
    Corner, A.
    Eliasson, B.
    Shaginian, R. M.
    Wu, Y.
    Yan, P.
    Heine, R. J.
    Smith, U.
    Taskinen, M. -R.
    Yki-Jarvinen, H.
    Diamant, M.
    DIABETOLOGIA, 2009, 52 : S7 - S7
  • [44] Metformin prevents weight gain and improves cardiovascular outcome in patients with type 2 diabetes intensively treated with insulin
    Kooy, Adriaan
    De Jager, Jolien
    Lehert, Philippe
    Bets, Daniel
    Wulffele, Michiel G.
    Donker, Ab J.
    Stehouwer, Coen D.
    DIABETES, 2007, 56 : A154 - A154
  • [45] Pioglitazone improves the cardio-ankle vascular index in patients with type 2 diabetes mellitus treated with metformin
    Ohira, Masahiro
    Yamaguchi, Takashi
    Saiki, Atsuhito
    Ban, Noriko
    Kawana, Hidetoshi
    Nagumo, Ayako
    Murano, Takeyoshi
    Shirai, Kohji
    Tatsuno, Ichiro
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2014, 7 : 313 - 319
  • [46] Treatment intensification with insulin degludec improves glycaemic control in patients with Type 2 diabetes treated with liraglutide and metformin
    Kumar, S.
    Aroda, V.
    Bailey, T.
    Cariou, B.
    Leiter, L.
    Raskin, P.
    Zacho, J.
    Philis-Tsimikas, A.
    DIABETIC MEDICINE, 2015, 32 : 66 - 66
  • [47] Rosiglitazone in combination with metformin effectively reduces hyperglycemia in patients with type 2 diabetes.
    Fonseca, V
    Biswas, N
    Salzman, A
    DIABETOLOGIA, 1999, 42 : A230 - A230
  • [48] PATIENT REPORTED OUTCOMES ARE SUPERIOR IN PATIENTS WITH TYPE 2 DIABETES TREATED WITH LIRAGLUTIDE AS COMPARED TO EXENATIDE, WHEN ADDED TO METFORMIN, SULFONYLUREA OR BOTH
    Schmidt, W. E.
    Christiansen, J. S.
    Hammer, M.
    Zychma, M. J.
    Buse, J.
    VALUE IN HEALTH, 2009, 12 (03) : A105 - A105
  • [49] Linagliptin plus metformin in patients with newly diagnosed type 2 diabetes and marked hyperglycemia
    Ross, Stuart A.
    Caballero, A. Enrique
    Del Prato, Stefano
    Gallwitz, Baptist
    Lewis-D'Agostino, Diane
    Bailes, Zelie
    Thiemann, Sandra
    Patel, Sanjay
    Woerle, Hans-Juergen
    von Eynatten, Maximilian
    POSTGRADUATE MEDICINE, 2016, 128 (08) : 747 - 754
  • [50] Study of Postprandial Lipaemia in Type 2 Diabetes Mellitus: Exenatide versus Liraglutide
    Voukali, Maria
    Kastrinelli, Irene
    Stragalinou, Sapfo
    Tasiopoulou, Dimitra
    Paraskevopoulou, Pinelopi
    Katsilambros, Nicholas
    Kokkinos, Alexandros
    Tentolouris, Nicholas
    Ioannidis, Ioannis
    JOURNAL OF DIABETES RESEARCH, 2014, 2014
12345